Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 13:10:958669.
doi: 10.3389/fbioe.2022.958669. eCollection 2022.

Methods and criteria for validating the multimodal functions of perinatal derivatives when used in oncological and antimicrobial applications

Affiliations
Review

Methods and criteria for validating the multimodal functions of perinatal derivatives when used in oncological and antimicrobial applications

Antonietta R Silini et al. Front Bioeng Biotechnol. .

Abstract

Perinatal derivatives or PnDs refer to tissues, cells and secretomes from perinatal, or birth-associated tissues. In the past 2 decades PnDs have been highly investigated for their multimodal mechanisms of action that have been exploited in various disease settings, including in different cancers and infections. Indeed, there is growing evidence that PnDs possess anticancer and antimicrobial activities, but an urgent issue that needs to be addressed is the reproducible evaluation of efficacy, both in vitro and in vivo. Herein we present the most commonly used functional assays for the assessment of antitumor and antimicrobial properties of PnDs, and we discuss their advantages and disadvantages in assessing the functionality. This review is part of a quadrinomial series on functional assays for the validation of PnDs spanning biological functions such as immunomodulation, anticancer and antimicrobial, wound healing, and regeneration.

Keywords: biological assays; cancer; functional assays; infections; mechanisms of action; perinatal derivatives; pharmacologic actions; potency assays.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Allen H., Shraga-Heled N., Blumenfeld M., Dego-Ashto T., Fuchs-Telem D., Gilert A., et al. (2018). Human placental-derived adherent stromal cells Co-induced with TNF-alpha and IFN-gamma inhibit triple-negative breast cancer in nude mouse xenograft models. Sci. Rep. 8 (1), 670. 10.1038/s41598-017-18428-1 - DOI - PMC - PubMed
    1. Alshareeda A. T., Rakha E., Alghwainem A., Alrfaei B., Alsowayan B., Albugami A., et al. (2018). The effect of human placental chorionic villi derived mesenchymal stem cell on triple-negative breast cancer hallmarks. PLoS One 13 (11), e0207593. 10.1371/journal.pone.0207593 - DOI - PMC - PubMed
    1. Ashraf H., Font K., Powell C., Schurr M. (2019). Antimicrobial activity of an amnion-chorion membrane to oral microbes. Int. J. Dent. 2019, 1269534. 10.1155/2019/1269534 - DOI - PMC - PubMed
    1. Ayuzawa R., Doi C., Rachakatla R. S., Pyle M. M., Maurya D. K., Troyer D., et al. (2009). Naive human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo . Cancer Lett. 280 (1), 31–37. 10.1016/j.canlet.2009.02.011 - DOI - PMC - PubMed
    1. Bajetto A., Pattarozzi A., Corsaro A., Barbieri F., Daga A., Bosio A., et al. (2017). Different effects of human umbilical cord mesenchymal stem cells on glioblastoma stem cells by direct cell interaction or via released soluble factors. Front. Cell. Neurosci. 11, 312. 10.3389/fncel.2017.00312 - DOI - PMC - PubMed